This is the fourth in a series of CEO short interviews about their views on their company, the digital pathology market, lessons learned and perhaps a little insight into their business principles.  My personal thanks to Ms. Shiposh and the...

Partnership is intended to overcome limitations of existing methods, widening the range of genetic abnormalities that can be screened.  Carlsbad CA, US and Sarcelles, FRANCE – November 4, 2015 – Applied Spectral Imaging (ASI,...

June 4-6, 2015 Booth # 2P Hyatt Regency Savannah, Georgia See the new capabilities of the GenASIs Cytogenetics Suite for Karyotyping and FISH Solutions for Any Sized Lab Superior solutions for FISH and Karyotyping Infinite...

Carlsbad, CA. – April 16, 2015 – Applied Spectral Imaging (ASI, www.spectral-imaging.com) announced today that it has received clearance from the South Korean Ministry of Food and Drug Safety (MFDS) for its GenASIs HiPath image capture and...

Three Events - One Product Family! Join Applied Spectral Imaging at the following events in March to learn about ASI’s GenASIs Platform. Accurate. Standardized. Immediate USCAP 2015 - United States & Canadian Academy of...

Carlsbad, CA. - January 21, 2015 - Applied Spectral Imaging (ASI, www.spectral-imaging.com) announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its GenASIs HiPath image capture and analysis...